1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

24 May 2025
Admin
News Article

Twist, Element Biosciences Co-Develop NGS End-to-End Solutions

Twist Bioscience Corporation (NASDAQ: TWST), a synthetic biology company providing high-quality DNA synthesis tools, and Element Biosciences, Inc., a developer of affordable, high-accuracy sequencing technology, have announced an expanded strategic collaboration to enhance next-generation sequencing (NGS) workflows on Element’s AVITI™ systems and Trinity™ flowcells.

A New Era in Targeted Sequencing

The partnership will enable:

Exclusive development of Twist's library preparation and target enrichment workflows compatible with Element’s Trinity sequencing technology
Expansion beyond exome sequencing into broader NGS applications, enhancing data quality, workflow consistency, and user flexibility

Executive Perspectives

“This expanded collaboration enables us to deliver industry-leading library prep and enrichment solutions, radically streamlining hybrid capture workflows both on and off the sequencer.”

Emily M. Leproust, CEO and Co-founder, Twist Bioscience

“By uniting Trinity’s targeted sequencing with Twist’s precision NGS tools, we’re democratizing access to cutting-edge genomics solutions and accelerating discovery.”

Molly He, CEO and Co-founder, Element Biosciences

Benefits to Researchers

End-to-end integration from library prep to sequencing on the AVITI platform
Improved workflow efficiency with Twist’s 1-hour fast hybridization technology
Expanded access to high-quality sequencing for agbio, clinical research, and population genomics
This collaboration also includes joint commercial and promotional efforts to increase adoption and market reach.

About the Companies

Twist Bioscience Corporation

Twist delivers precision synthetic DNA at scale, serving sectors like medicine, agriculture, chemicals, and defense. Its silicon-ased DNA synthesis platform ensures high throughput and accuracy, enabling faster innovation.

Element Biosciences, Inc.

Element is transforming sequencing accessibility through Trinity, an advanced workflow that delivers high-quality, affordable data. The company innovates across all assay elements to improve user experience and scientific outcomes.